IPS_004 - Quality control of radiopharmaceuticals: Case of Fluorodeoxyglucose (FDG)

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: IPS_003
• By: NEGGAZI, Sarah (University of Algiers 1, Faculty of Pharmacy, Algeria)
• Co-author(s): Dr Sarah Neggazi (University of Algiers 1, Faculty of Pharmacy, Algiers, Algeria / Ali Ait Idir Neurosurgery Hospital, Algiers , Algeria)
  Dr Manel Belkhatir (University of Algiers 1, Faculty of Pharmacy, Algiers, Algeria / Ali Ait Idir Neurosurgery Hospital, Algiers , Algeria)
  Prof El Mansouria Nebchi (University of Algiers 1, Faculty of Pharmacy, Algiers, Algeria / Ali Ait Idir Neurosurgery Hospital, Algiers , Algeria)
  
• Abstract:

  Introduction
  The Quality Control (QC) of Radiopharmaceuticals is a critical aspect in ensuring patient safety and the efficacy of diagnostic and therapeutic applications. Fluorodeoxyglucose's (FDG) short half-life and its combined pharmaceutical and nuclear properties require stringent and precise quality control measures to meet regulatory..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login